These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25253196)

  • 1. Projection scenarios of body mass index (2013-2030) for Public Health Planning in Quebec.
    Lo E; Hamel D; Jen Y; Lamontagne P; Martel S; Steensma C; Blouin C; Steele R
    BMC Public Health; 2014 Sep; 14():996. PubMed ID: 25253196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Region-level obesity projections and an examination of its correlates in Quebec.
    Jahagirdar D; Lo E
    Can J Public Health; 2017 Jun; 108(2):e162-e168. PubMed ID: 28621652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes and obesity trends in Fiji over 30 years.
    Lin S; Tukana I; Linhart C; Morrell S; Taylor R; Vatucawaqa P; Magliano DJ; Zimmet P
    J Diabetes; 2016 Jul; 8(4):533-43. PubMed ID: 26201444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Association of Pension Income with the Incidence of Type I Obesity among Retired Israelis.
    Arbel Y; Fialkoff C; Kerner A
    J Obes; 2019; 2019():5101867. PubMed ID: 31428470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity prevalence in Mexico: impact on health and economic burden.
    Rtveladze K; Marsh T; Barquera S; Sanchez Romero LM; Levy D; Melendez G; Webber L; Kilpi F; McPherson K; Brown M
    Public Health Nutr; 2014 Jan; 17(1):233-9. PubMed ID: 23369462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of age-specific and sex-specific overweight and obesity in Ontario and Quebec, Canada: a cross-sectional study using direct measures of height and weight.
    Thielman J; Harrington D; Rosella LC; Manson H
    BMJ Open; 2018 Sep; 8(9):e022029. PubMed ID: 30185572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a population-based microsimulation model of body mass index.
    Hennessy D; Garner R; Flanagan WM; Wall R; Nadeau C
    Health Rep; 2017 Jun; 28(6):20-30. PubMed ID: 28636070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of metabolic alterations predictive of cardiovascular disease risk in the Québec population.
    Scarsella C; Alméras N; Mauriège P; Blanchet C; Sauvé L; Dewailly E; Bergeron J; Després JP
    Can J Cardiol; 2003 Jan; 19(1):51-7. PubMed ID: 12571695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in diabetes and obesity in Samoa over 35 years, 1978-2013.
    Lin S; Naseri T; Linhart C; Morrell S; Taylor R; McGarvey ST; Magliano DJ; Zimmet P
    Diabet Med; 2017 May; 34(5):654-661. PubMed ID: 27505623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of obesity in an elderly Hungarian population.
    Kiss C; Poór G; Donáth J; Gergely P; Paksy A; Zajkás G; Antal M
    Eur J Epidemiol; 2003; 18(7):653-7. PubMed ID: 12952138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The future burden of obesity-related diseases in the 53 WHO European-Region countries and the impact of effective interventions: a modelling study.
    Webber L; Divajeva D; Marsh T; McPherson K; Brown M; Galea G; Breda J
    BMJ Open; 2014 Jul; 4(7):e004787. PubMed ID: 25063459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence estimates of diabetes and of other cardiovascular risk factors in the two largest Algonquin communities of Quebec.
    Delisle HF; Rivard M; Ekoé JM
    Diabetes Care; 1995 Sep; 18(9):1255-9. PubMed ID: 8612439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Projections of trends in overweight in the elderly population in Germany until 2030 and international comparison.
    Westphal C; Doblhammer G
    Obes Facts; 2014; 7(1):57-68. PubMed ID: 24525549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolically healthy and unhealthy obesity phenotypes in the general population: the FIN-D2D Survey.
    Pajunen P; Kotronen A; Korpi-Hyövälti E; Keinänen-Kiukaanniemi S; Oksa H; Niskanen L; Saaristo T; Saltevo JT; Sundvall J; Vanhala M; Uusitupa M; Peltonen M
    BMC Public Health; 2011 Oct; 11():754. PubMed ID: 21962038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic disease burden associated with overweight and obesity in Ireland: the effects of a small BMI reduction at population level.
    Kearns K; Dee A; Fitzgerald AP; Doherty E; Perry IJ
    BMC Public Health; 2014 Feb; 14():143. PubMed ID: 24512151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Forecasting Tunisian type 2 diabetes prevalence to 2027: validation of a simple model.
    Saidi O; O'Flaherty M; Mansour NB; Aissi W; Lassoued O; Capewell S; Critchley JA; Malouche D; Romdhane HB;
    BMC Public Health; 2015 Feb; 15():104. PubMed ID: 25885910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic syndrome and chronic disease.
    Rao DP; Dai S; Lagacé C; Krewski D
    Chronic Dis Inj Can; 2014 Feb; 34(1):36-45. PubMed ID: 24618380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.
    Wild S; Roglic G; Green A; Sicree R; King H
    Diabetes Care; 2004 May; 27(5):1047-53. PubMed ID: 15111519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Projection of older Australians with a history of midlife obesity and overweight 2010-2050.
    Nepal B; Brown L
    Obesity (Silver Spring); 2013 Dec; 21(12):2579-81. PubMed ID: 23670999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of non-insulin-dependent diabetes mellitus and impaired glucose tolerance in two Algonquin communities in Quebec.
    Delisle HF; Ekoé JM
    CMAJ; 1993 Jan; 148(1):41-7. PubMed ID: 8439889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.